Parallax Volatility Advisers
ALXN

Parallax Volatility Advisers’s Alexion Pharmaceuticals ALXN Stock Holding History

Parallax Volatility Advisers’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-19,394
Closed -$3.56M – 3664
2021
Q2 		$3.56M Sell
19,394
-7,596
-28% -$1.3M ﹤0.01% 1401
2021
Q1 		$4.13M Buy
26,990
+12,970
+93% +$2.01M ﹤0.01% 1386
2020
Q4 		$2.19M Buy
14,020
+12,839
+1,087% +$1.65M ﹤0.01% 1852
2020
Q3 		$135K Sell
1,181
-56,376
-98% -$6.08M ﹤0.01% 2650
2020
Q2 		$6.46M Buy
57,557
+10,585
+23% +$1.12M 0.01% 979
2020
Q1 		$4.22M Buy
46,972
+38,092
+429% +$3.74M 0.01% 933
2019
Q4 		$960K Buy
8,880
+3,723
+72% +$398K ﹤0.01% 1537
2019
Q3 		$505K Buy
+5,157
New +$581K ﹤0.01% 1596
2019
Q1 		– Sell
-18,386
Closed -$2.29M – 4389
2018
Q4 		$1.79M Buy
+18,386
New +$2.17M ﹤0.01% 1097
2018
Q2 		– Sell
-635
Closed -$71K – 3648
2018
Q1 		$71K Sell
635
-5,550
-90% -$663K ﹤0.01% 1429
2017
Q4 		$740K Buy
+6,185
New +$753K ﹤0.01% 1310
2015
Q4 		– Sell
-6,754
Closed -$1.18M – 4186
2015
Q3 		$1.06M Sell
6,754
-4,674
-41% -$853K ﹤0.01% 1267
2015
Q2 		$2.07M Buy
+11,428
New +$1.97M ﹤0.01% 1054
2015
Q1 		– Sell
-2,664
Closed -$493K – 5848
2014
Q4 		$493K Buy
+2,664
New +$494K ﹤0.01% 2063
2014
Q2 		– Sell
-39,789
Closed -$6.05M – 4378
2014
Q1 		$6.05M Buy
+39,789
New +$6.33M 0.04% 347

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Parallax Volatility Advisers's ALXN Position: Q3 2021 in Review

Parallax Volatility Advisers sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 19,394 shares — an estimated $3.56M sold.

Parallax Volatility Advisers first reported a position in ALXN in Q1 2014 and held it in 15 quarters. The position peaked at $6.46M in Q2 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Parallax Volatility Advisers reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 19,394 Alexion Pharmaceuticals shares in Q3 2021, an estimated $3.56M.
  • Parallax Volatility Advisers first reported a position in Alexion Pharmaceuticals in Q1 2014 and held it in 15 quarters.
  • Parallax Volatility Advisers's Alexion Pharmaceuticals position peaked at $6.46M in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Parallax Volatility Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.